Monopar Therapeutics, Inc. (MNPR)
59.27
-1.72
(-2.82%)
USD |
NASDAQ |
May 15, 16:00
59.42
+0.15
(+0.25%)
After-Hours: 20:00
Monopar Therapeutics Debt to Equity Ratio : 0.001 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Anika Therapeutics, Inc. | 0.1922 |
| BioCryst Pharmaceuticals, Inc. | -1.549 |
| Plus Therapeutics, Inc. | 0.0606 |
| Perspective Therapeutics, Inc. | 0.0122 |
| AVITA Medical, Inc. | -2.077 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 137.98M |
| Total Liabilities (Quarterly) | 2.589M |
| Shareholders Equity (Quarterly) | 135.39M |
| Current Ratio | 56.05 |
| Net Debt Paydown Yield | -0.01% |